Thomas J Velenosi1, Gil Ben-Yakov2, Maren C Podszun2, Julian Hercun3, Ohad Etzion3, Shanna Yang4, Cathy Nadal3, Vanessa Haynes-Williams3, Wen-Chun A Huang3, Lila González-Hódar2, Robert J Brychta5, Shogo Takahashi1, Vikas Akkaraju1, Kristopher W Krausz1, Mary Walter6, Hongyi Cai7, Peter J Walter7, Ranganath Muniyappa5, Kong Y Chen5, Frank J Gonzalez1, Yaron Rotman8. 1. Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland. 2. Liver and Energy Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland. 3. Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland. 4. Nutrition Department, NIH Clinical Center, Bethesda, Maryland. 5. Diabetes, Endocrinology, and Obesity Branch, NIDDK, NIH, Bethesda, Maryland. 6. Clinical Laboratory Core, NIDDK, NIH, Bethesda, Maryland. 7. Clinical Mass Spectrometry Core, NIDDK, NIH, Bethesda, Maryland. 8. Liver and Energy Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland. Electronic address: rotmany@niddk.nih.gov.
Abstract
BACKGROUND & AIMS: Hepatic energy metabolism is a dynamic process modulated by multiple stimuli. In nonalcoholic fatty liver disease (NAFLD), human studies typically focus on the static fasting state. We hypothesized that unique postprandial alterations in hepatic lipid metabolism are present in NAFLD. METHODS: In a prospective clinical study, 37 patients with NAFLD and 10 healthy control subjects ingested a standardized liquid meal with pre- and postprandial blood sampling. Postprandial plasma lipid kinetics were characterized at the molecular lipid species level by untargeted lipidomics, cluster analysis, and lipid particle isolation, then confirmed in a mouse model. RESULTS: There was a specific increase of multiple plasma diacylglycerol (DAG) species at 4 hours postprandially in patients with NAFLD but not in controls. This was replicated in a nonalcoholic steatohepatitis mouse model, where postprandial DAGs increased in plasma and concomitantly decreased in the liver. The increase in plasma DAGs appears early in the disease course, is dissociated from NAFLD severity and obesity, and correlates with postprandial insulin levels. Immunocapture isolation of very low density lipoprotein in human samples and stable isotope tracer studies in mice revealed that elevated postprandial plasma DAGs reflect hepatic secretion of endogenous, rather than meal-derived lipids. CONCLUSIONS: We identified a selective insulin-related increase in hepatic secretion of endogenously derived DAGs after a mixed meal as a unique feature of NAFLD. DAGs are known to be lipotoxic and associated with atherosclerosis. Although it is still unknown whether the increased exposure to hepatic DAGs contributes to extrahepatic manifestations and cardiovascular risk in NAFLD, our study highlights the importance of extending NAFLD research beyond the fasting state. Published by Elsevier Inc.
BACKGROUND & AIMS: Hepatic energy metabolism is a dynamic process modulated by multiple stimuli. In nonalcoholic fatty liver disease (NAFLD), human studies typically focus on the static fasting state. We hypothesized that unique postprandial alterations in hepatic lipid metabolism are present in NAFLD. METHODS: In a prospective clinical study, 37 patients with NAFLD and 10 healthy control subjects ingested a standardized liquid meal with pre- and postprandial blood sampling. Postprandial plasma lipid kinetics were characterized at the molecular lipid species level by untargeted lipidomics, cluster analysis, and lipid particle isolation, then confirmed in a mouse model. RESULTS: There was a specific increase of multiple plasma diacylglycerol (DAG) species at 4 hours postprandially in patients with NAFLD but not in controls. This was replicated in a nonalcoholic steatohepatitis mouse model, where postprandial DAGs increased in plasma and concomitantly decreased in the liver. The increase in plasma DAGs appears early in the disease course, is dissociated from NAFLD severity and obesity, and correlates with postprandial insulin levels. Immunocapture isolation of very low density lipoprotein in human samples and stable isotope tracer studies in mice revealed that elevated postprandial plasma DAGs reflect hepatic secretion of endogenous, rather than meal-derived lipids. CONCLUSIONS: We identified a selective insulin-related increase in hepatic secretion of endogenously derived DAGs after a mixed meal as a unique feature of NAFLD. DAGs are known to be lipotoxic and associated with atherosclerosis. Although it is still unknown whether the increased exposure to hepatic DAGs contributes to extrahepatic manifestations and cardiovascular risk in NAFLD, our study highlights the importance of extending NAFLD research beyond the fasting state. Published by Elsevier Inc.
Authors: Elisa Fabbrini; B Selma Mohammed; Faidon Magkos; Kevin M Korenblat; Bruce W Patterson; Samuel Klein Journal: Gastroenterology Date: 2007-11-28 Impact factor: 22.682
Authors: Faidon Magkos; Xiong Su; David Bradley; Elisa Fabbrini; Caterina Conte; J Christopher Eagon; J Esteban Varela; Elizabeth M Brunt; Bruce W Patterson; Samuel Klein Journal: Gastroenterology Date: 2012-03-13 Impact factor: 22.682
Authors: Panu K Luukkonen; Sami Qadri; Tiina E Lehtimäki; Anne Juuti; Henna Sammalkorpi; Anne K Penttilä; Antti Hakkarainen; Marju Orho-Melander; Johanna Arola; Hannele Yki-Järvinen Journal: J Clin Endocrinol Metab Date: 2021-01-01 Impact factor: 5.958
Authors: Richard B Heath; Fredrik Karpe; Ross W Milne; Graham C Burdge; Stephen A Wootton; Keith N Frayn Journal: Am J Physiol Endocrinol Metab Date: 2006-11-07 Impact factor: 4.310
Authors: Astrid M Moerman; Mirjam Visscher; Nuria Slijkhuis; Kim Van Gaalen; Bram Heijs; Theo Klein; Peter C Burgers; Yolanda B De Rijke; Heleen M M Van Beusekom; Theo M Luider; Hence J M Verhagen; Antonius F W Van der Steen; Frank J H Gijsen; Kim Van der Heiden; Gijs Van Soest Journal: J Lipid Res Date: 2021-01-06 Impact factor: 5.922
Authors: Abudukadier Abulizi; Daniel F Vatner; Zhang Ye; Yongliang Wang; Joao-Paulo Camporez; Dongyan Zhang; Mario Kahn; Kun Lyu; Alaa Sirwi; Gary W Cline; M Mahmood Hussain; Patricia Aspichueta; Varman T Samuel; Gerald I Shulman Journal: J Lipid Res Date: 2020-09-09 Impact factor: 5.922